Table 2 Clinical and histopathological characteristics of patients with gastric cancer enrolled to generate PDXs in zebrafish
Patient # | Sex | Age (years) | Tumor size(cm) | Pathological type | Lauren | T N M | Number of metastasis lymph nodes |
|---|---|---|---|---|---|---|---|
1 | M | 64 | 4.5 × 4 × 1.5 | Adenocarcinoma (II-III) | Intestinal | 3 2 0 | 6/42 |
2 | M | 66 | 4 × 3 × 1 | Adenocarcinoma (II-III) | Hybrid | 2 2 0 | 5/39 |
3 | M | 56 | 2 × 2 × 1.2 | Adenocarcinoma (II-III) | Hybrid | 3 0 0 | 0/53 |
4 | F | 47 | 6.5 × 5 × 1.5 | Adenocarcinoma (II-III) | Intestinal | 3 0 0 | 0/39 |
5 | M | 64 | 4 × 3 × 2.5 | Poorly differentiated adenocarcinoma | Diffuse | 4 3b 0 | 26/52 |
6 | M | 64 | 4.5 × 2.5 × 1 | Adenocarcinoma (II-III) | Hybrid | 2 0 0 | 0/31 |
7 | M | 64 | 4 × 3.3 × 0.5 | Adenocarcinoma (II-III) | Hybrid | 3 2 0 | 4/33 |
8 | M | 67 | 7 × 6.3 × 3 | Poorly differentiated adenocarcinoma | Diffuse | 4 1 0 | 1/31 |
9 | M | 62 | 10.5 × 9 × 2.1 | Adenocarcinoma (II-III) | Intestinal | 4 3 0 | 8/46 |